Catheter Precision stockholders approve share issuance, authorized share increase, and equity plan expansion

Catheter Precision, Inc.

Approved issuance of up to 10.7M shares upon exercise of Series K Warrants; 1.4M for, 833K against, 1.9M broker non-votes.
Approved amendment to increase authorized common shares from 30M to 60M; 2.8M for, 1.4M against.
Approved additional 1.5M shares for 2023 Equity Incentive Plan; 1.8M for, 426K against, 1.9M broker non-votes.
Ratified WithumSmith+Brown as auditor for FY2025; 3.7M for, 434K against, 23K abstain.
Legal opinion condition on authorized share increase satisfied; revised opinion filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.